Novel anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly.

about

Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation.Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting.

P2860

Q37139657-42E2F4F8-C451-46E2-890E-4D2396CD3819 Q47547612-549CABFA-6891-456B-9579-E5C997A0481A

P2860

Novel anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly.

Item

http://www.wikidata.org/entity/Q38155933

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Novel anticoagulants for strok ...... safety issues in the elderly.

@en

type

Item

label

Novel anticoagulants for strok ...... safety issues in the elderly.

@en

prefLabel

Novel anticoagulants for strok ...... safety issues in the elderly.

@en

P1476

Novel anticoagulants for strok ...... safety issues in the elderly.

@en

P2093

Anton Strunets

http://www.w3.org/2001/XMLSchema#string

Arshad Jahangir

http://www.w3.org/2001/XMLSchema#string

Jasbir Sra

http://www.w3.org/2001/XMLSchema#string

Mahek Mirza

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban--an oral, direct factor Xa inhibitor--are not affected by aspirin

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Dabigatran versus warfarin in patients with atrial fibrillation

Direct thrombin inhibitors

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

P304

677-689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.2013.842125

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24164615

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

Novel anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly.

about

P2860

P2860

Novel anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921